Tucotuzumab celmoleukin: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiPro |
Entranced98 (talk | contribs) Adding local short description: "Monoclonal antibody drug", overriding Wikidata description "chemical compound" |
||
| (12 intermediate revisions by 10 users not shown) | |||
| Line 1: | Line 1: | ||
| ⚫ | |||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = |
||
| image = |
| image = |
||
<!-- Monoclonal antibody data --> |
|||
| ⚫ | |||
| type = mab |
| type = mab |
||
| mab_type = mab |
| mab_type = mab |
||
| source = zu/o |
| source = zu/o |
||
| target = [[EpCAM]] |
| target = [[EpCAM]] |
||
| ⚫ | |||
| ⚫ | |||
| tradename = |
| tradename = |
||
| pregnancy_AU = |
| pregnancy_AU = |
||
| Line 20: | Line 19: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
| ⚫ | |||
| ⚫ | |||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| Line 27: | Line 25: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| ⚫ | |||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| ⚫ | |||
| CAS_number = 339986-90-2 |
| CAS_number = 339986-90-2 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 4ON7FF680U |
|||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| Line 37: | Line 37: | ||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D09027 |
| KEGG = D09027 |
||
| ChemSpiderID = none |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=7812 | H=12124 | N=2044 | O=2408 | S=60 |
| C=7812 | H=12124 | N=2044 | O=2408 | S=60 |
||
| molecular_weight = 175.1 [[kDa]] |
|||
}} |
}} |
||
'''Tucotuzumab celmoleukin''' is an anti-[[cancer]] drug. It is a [[fusion protein]] of a [[ |
'''Tucotuzumab celmoleukin''' is an anti-[[cancer]] drug. It is a [[fusion protein]] of a [[ monoclonal antibody]] (tucotuzumab) and an [[interleukin-2]] (celmoleukin).<ref>[http://www.ama-assn.org/ama1/pub/upload/mm/365/t_celmoleukin.pdf Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin], ''American Medical Association''.</ref><ref>NCT00016237</ref><ref>http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=456358 National Cancer Institute Definition of tucotuzumab celmoleukin</ref> |
||
This drug was developed by [[EMD Pharmaceuticals]]. |
This drug was developed by [[EMD Pharmaceuticals]]. |
||
== References == |
== References == |
||
{{Reflist}} |
|||
<references/> |
|||
{{Monoclonals for tumors}} |
{{Monoclonals for tumors}} |
||
{{Interleukin receptor modulators}} |
|||
[[Category:Monoclonal antibodies for tumors]] |
[[Category:Monoclonal antibodies for tumors]] |
||
[[Category:Antibody-drug conjugates]] |
|||
{{monoclonal-antibody-stub}} |
{{monoclonal-antibody-stub}} |
||
{{antineoplastic-drug-stub}} |
{{antineoplastic-drug-stub}} |
||
[[it:Tucotuzumab celmoleukin]] |
|||